Dr Peter Pfeilschifter assumes role of CEO at Pharmalys Laboratories SA

26.08.2019 17:45

HOCHDORF Group Press Release: New CEO at Pharmalys Laboratories SA

Hochdorf, 26 August 2019 – Dr Peter Pfeilschifter, currently Chairman of the Board of Directors at Pharmalys Laboratories SA, is to take on the role of CEO at Pharmalys Laboratories SA with immediate effect. Dr Pfeilschifter will take responsibility for the operational business in the next few days. The interim CEO of the HOCHDORF Group will be supported in this additional role by Baby Care team employees at HOCHDORF Swiss Nutrition Ltd. The new CEO appointment became necessary when Amir Mechria resigned from all his responsibilities at Pharmalys Laboratories SA. This development means that HOCHDORF assumes responsibility for the operational business of Pharmalys Laboratories SA.


Dr Christoph Hug, Head of Corporate Communications HOCHDORF Group, Tel:+41 (0)41 914 65 62 / +41 (0)79 859 19 23, christoph.hug@hochdorf.com.


About the HOCHDORF Group:
The HOCHDORF Group, based in Hochdorf, achieved a consolidated gross sales revenue of CHF 561.0 million in 2018. It is one of the leading foodstuff companies in Switzerland, employing over 694 staff as of 31.12.2018.Made from natural ingredients such as milk, wheat germ and oil seeds, HOCHDORF products have been contributing to our health and wellbeing since 1895 – from babies to senior citizens. Its customers include the food industry and the wholesale and retail sectors. Its products are sold in over 90 countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528).